NASDAQ:MARAMarathon Patent Group Stock Price, Forecast & News

Marathon Patent Group's stock was trading at $0.71 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MARA stock has increased by 28.2% and is now trading at $0.9101. View which stocks have been most impacted by Coronavirus.

Marathon Patent Group is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Marathon Patent Group.

Marathon Patent Group Inc (NASDAQ:MARA) announced its quarterly earnings data on Thursday, May, 14th. The business services provider reported ($0.12) EPS for the quarter. The business services provider earned $0.59 million during the quarter. Marathon Patent Group had a negative return on equity of 117.37% and a negative net margin of 228.04%. View Marathon Patent Group's earnings history.

Shares of Marathon Patent Group reverse split on the morning of Monday, October 30th 2017. The 1-4 reverse split was announced on Friday, October 27th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Friday, October 27th 2017. An investor that had 100 shares of Marathon Patent Group stock prior to the reverse split would have 25 shares after the split.

Media stories about MARA stock have trended somewhat positive recently, according to InfoTrie. The research firm identifies positive and negative press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Marathon Patent Group earned a coverage optimism score of 1.6 on InfoTrie's scale. They also gave headlines about the business services provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news about Marathon Patent Group.

Some companies that are related to Marathon Patent Group include Finjan (FNJN), XCel Brands (XELB), MGT Capital Investments (MGTI), Health Discovery (HDVY), Spherix (SPEX), ARC Group (ARCK), American Restaurant Partners LP Class A Partnership Units (ICTPU), Fortel (ECGP), Micro Imaging Technology (MMTC) and Patriot Scientific (PTSC). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Marathon Patent Group investors own include Sierra Wireless (SWIR), Bausch Health Companies (BHC), Alibaba Group (BABA), MannKind (MNKD), Riot Blockchain (RIOT), Biocept (BIOC), Neovasc (NVCN), Micron Technology (MU), PTC Therapeutics (PTCT) and Arena Pharmaceuticals (ARNA).

Marathon Patent Group trades on the NASDAQ under the ticker symbol "MARA."

Shares of MARA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of MARA stock can currently be purchased for approximately $0.91.

Marathon Patent Group has a market capitalization of $18.42 million and generates $1.18 million in revenue each year. Marathon Patent Group employs 3 workers across the globe.

The official website for Marathon Patent Group is www.marathonpg.com.

Marathon Patent Group's mailing address is 1180 North Town Center Drive Suite 100, LAS VEGAS NV, 89144. The business services provider can be reached via phone at 702-945-2773 or via email at [email protected]